K Prabhash Selected Research

Therapeutics

10/2022	Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial.
4/2017	Carboplatin-based concurrent chemoradiation therapy in locally advanced head and neck cancer patients who are unfit for cisplatin therapy.
1/2017	Palliative thoracic radiotherapy in advanced lung cancer: A single institution experience.
10/2016	Patterns of care and outcomes for second-line targeted therapy in metastatic renal cell carcinomas: A registry based analysis.
1/2016	Current evidence and the evolving role of sunitinib in the management of renal cell carcinoma.
1/2015	Is taxane/platinum/5 fluorouracil superior to taxane/platinum alone and does docetaxel trump paclitaxel in induction therapy for locally advanced oral cavity cancers?
1/2015	Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung.
10/2014	Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers.
10/2014	Leptomeningeal metastasis in solid tumors with a special focus on lung cancer.
10/2014	Pattern of infection, therapy, outcome and risk stratification of patients with febrile neutropenia in a tertiary care oncology hospital in India.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Prabhash Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 01/2006
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2017 - 12/2010
9	Lung Neoplasms (Lung Cancer) 01/2018 - 11/2014
8	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2013
6	Carcinoma (Carcinomatosis) 01/2019 - 01/2013
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2016 - 07/2013
4	Infections 10/2014 - 10/2009
3	Adenocarcinoma of Lung 01/2017 - 01/2015
3	Febrile Neutropenia 04/2016 - 01/2013
2	Esophageal Neoplasms (Esophageal Cancer) 10/2022 - 04/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 09/2016
2	Brain Neoplasms (Brain Tumor) 01/2018 - 12/2010
2	Adenocarcinoma 01/2018 - 07/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017 - 04/2013
2	Disease Progression 09/2016 - 07/2013
2	Exanthema (Rash) 07/2016 - 01/2016
2	Mouth Neoplasms (Oral Cancer) 12/2015 - 04/2013
2	Leukemia 01/2011 - 01/2009
2	Acute Promyelocytic Leukemia 01/2011 - 01/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2008 - 07/2007
2	Lymphoma (Lymphomas) 07/2008 - 07/2007
1	Esophageal Squamous Cell Carcinoma 10/2022
1	Seminoma 01/2021
1	Nasopharyngeal Carcinoma 12/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Sensorineural Hearing Loss 04/2017
1	Thoracic Diseases 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Vomiting 07/2016
1	Mucositis 07/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2016
1	Diarrhea 01/2016
1	Pulmonary Atelectasis 07/2015
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Hematologic Neoplasms (Hematological Malignancy) 10/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2014
1	Prostatic Neoplasms (Prostate Cancer) 07/2014
1	Laryngeal Neoplasms (Laryngeal Cancer) 04/2014
1	Respiratory Sounds (Crackle) 04/2014
1	Thymoma (Thymic Carcinoma) 04/2014

Drug/Important Bio-Agent (IBA)

7	Tyrosine Kinase InhibitorsIBA 01/2017 - 07/2013
6	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2013
5	Pharmaceutical PreparationsIBA 01/2017 - 07/2008
4	PlatinumIBA 01/2021 - 04/2013
4	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 01/2016
4	Anaplastic Lymphoma KinaseIBA 01/2017 - 04/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 04/2013
4	Docetaxel (Taxotere)FDA Link 09/2016 - 02/2004
3	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 07/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2014 - 10/2009
2	NivolumabIBA 01/2021 - 01/2017
2	taxaneIBA 12/2019 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 01/2015
2	CrizotinibIBA 04/2017 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2017 - 04/2013
2	Sunitinib (Sutent)FDA Link 01/2016 - 07/2013
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2015 - 04/2013
2	Retinoic Acid Receptor alphaIBA 01/2011 - 01/2009
2	Ceftazidime (Fortum)FDA LinkGeneric 04/2010 - 10/2009
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 04/2010 - 10/2009
1	nimotuzumabIBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2018
1	QuartzIBA 01/2018
1	CreatinineIBA 04/2017
1	Carboplatin (JM8)FDA LinkGeneric 04/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	Celecoxib (Celebrex)FDA Link 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	ceritinibIBA 01/2017
1	ParaffinIBA 01/2017
1	pazopanib FDA Link 10/2016
1	GoldIBA 10/2016
1	Sorafenib (BAY 43-9006)FDA Link 07/2016
1	AntiemeticsIBA 07/2016
1	CytokinesIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2015
1	Gefitinib (Iressa)FDA Link 10/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2014
1	Hemoglobins (Hemoglobin)IBA 10/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2014
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 10/2014
1	cabazitaxel FDA Link 07/2014

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 10/2022 - 07/2007
16	Therapeutics 10/2022 - 07/2007
8	Radiotherapy 01/2022 - 12/2010
7	Neoadjuvant Therapy 01/2018 - 01/2013
6	Induction Chemotherapy 12/2019 - 01/2013
3	Chemoradiotherapy 10/2022 - 07/2015
1	Image-Guided Radiotherapy 01/2022
1	Immunotherapy 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Aftercare (After-Treatment) 01/2018
1	Palliative Care (Palliative Therapy) 10/2015